Rhenman & Partners Asset Management Ab Repligen Corp Transaction History
Rhenman & Partners Asset Management Ab
- $1.2 Billion
- Q3 2024
A detailed history of Rhenman & Partners Asset Management Ab transactions in Repligen Corp stock. As of the latest transaction made, Rhenman & Partners Asset Management Ab holds 10,000 shares of RGEN stock, worth $1.39 Million. This represents 0.12% of its overall portfolio holdings.
Number of Shares
10,000
Previous 10,000
-0.0%
Holding current value
$1.39 Million
Previous $1.26 Million
18.1%
% of portfolio
0.12%
Previous 0.12%
Shares
3 transactions
Others Institutions Holding RGEN
# of Institutions
486Shares Held
54.3MCall Options Held
341KPut Options Held
235K-
Black Rock Inc. New York, NY7.57MShares$1.05 Billion0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD6.39MShares$888 Million0.11% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.04MShares$701 Million0.01% of portfolio
-
State Street Corp Boston, MA1.62MShares$226 Million0.01% of portfolio
-
Champlain Investment Partners, LLC Burlington, VT1.42MShares$197 Million1.34% of portfolio
About REPLIGEN CORP
- Ticker RGEN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 55,491,200
- Market Cap $7.71B
- Description
- Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....